Medication info

Candeta Plus Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Ilhwa Co., Ltd.
Appearance
Biconvex, pale pink rectangular tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 201310579 · Approved 2013.12.06

This product's status changed to Expired on 2023.12.06. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension not controlled with individual agents alone
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with or without food. 1) Adults: The dose of candesartan cilexetil should first be adjusted before switching to this medicine. When clinically appropriate, direct switching from monotherapy to this medicine may be considered. The antihypertensive effect is usually achieved within 4 weeks of starting treatment. 2) Elderly patients: No dose adjustment of this medicine is necessary in elderly patients. 3) Patients with intravascular volume depletion: In patients at risk of hypotension, such as those who may have reduced effective blood volume, adjustment of the candesartan cilexetil dose is recommended (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and a creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the dose of candesartan cilexetil before switching to this medicine (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance less than 30ml/mim/1.73㎡ BSA). 5) Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, adjusting the dose of candesartan cilexetil before administering this medicine is recommended (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Ingredients

Manufacturer
Ilhwa Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with individual agents alone

  • Essential hypertension
View approved original text

This medicine is used for patients with essential hypertension who do not achieve adequate effects with monotherapy using individual components. It helps to stabilize blood pressure, thereby reducing the risk of complications and maintaining healthy blood vessels. Therefore, it is effective for the treatment of essential hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with or without food. 1) Adults: The dose of candesartan cilexetil should first be adjusted before switching to this medicine. When clinically appropriate, direct switching from monotherapy to this medicine may be considered. The antihypertensive effect is usually achieved within 4 weeks of starting treatment. 2) Elderly patients: No dose adjustment of this medicine is necessary in elderly patients. 3) Patients with intravascular volume depletion: In patients at risk of hypotension, such as those who may have reduced effective blood volume, adjustment of the candesartan cilexetil dose is recommended (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and a creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the dose of candesartan cilexetil before switching to this medicine (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance less than 30ml/mim/1.73㎡ BSA). 5) Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, adjusting the dose of candesartan cilexetil before administering this medicine is recommended (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Precautions

This medicine can cause serious harm to the fetus and newborn, especially during the second and third trimesters of pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. Patients with a known allergy to any ingredients or sulfonamide derivatives in this medicine, pregnant women or those planning to become pregnant, and nursing mothers should not use this medicine. Patients with severely impaired kidney function, severe liver disease, or a history of angioedema are also advised not to take this medicine. Particular caution is needed for patients with low blood pressure or who have issues with fluid and electrolyte balance when using this medicine, and it is recommended to avoid taking it until symptoms improve. This medicine may increase the risk of skin sensitization to sunlight, raising the risk of skin cancer; thus, exposure to sunlight should be limited and protective measures taken while using this medicine. Common side effects may include headaches, dizziness, fatigue, and nausea, and serious side effects such as blood abnormalities or kidney function decline may occur rarely, so consult your doctor immediately if any abnormal symptoms appear. This medicine may affect kidney function, so patients with kidney disease should have regular blood tests to monitor kidney function and electrolyte levels. Drug interactions may occur if taken with other antihypertensive agents, diuretics, or potassium supplements, so administration should only be done after consulting a healthcare professional. Women who are pregnant or planning to become pregnant should not take this medicine, and nursing mothers should discontinue breastfeeding unless absolutely necessary while using this medicine. Elderly patients must be cautious as the medicine may cause excessively low blood pressure, leading to problems with the heart or cerebral blood vessels. In case of overdose, symptoms such as low blood pressure, dizziness, or electrolyte imbalance may occur, and appropriate treatment should be sought immediately at a medical facility. The safety and efficacy of this medicine in children and adolescents have not been established; therefore, it is advised not to use it in patients under 18 years old. Patients may experience dizziness or lethargy while taking this medicine, so caution should be exercised when driving or operating machinery. This medicine should be kept out of reach of children and stored in its original container to maintain its quality.

Side effects

  • Headache
  • back pain
  • dizziness
  • respiratory infections
  • symptoms resembling the flu
  • sinusitis
  • bronchitis
  • urinary tract infection
  • nausea
  • contusions
Show 72 more
  • tachycardia
  • fatigue
  • abdominal pain
  • pharyngitis
  • atrioventricular block
  • vomiting
  • dyslipidemia
  • nasopharyngitis
  • cough
  • increased blood sugar
  • elevated serum uric acid
  • increased ALT
  • decreased hemoglobin
  • increased serum AST
  • increased creatinine
  • increased urea
  • increased potassium
  • decreased sodium
  • leukopenia
  • neutropenia
  • agranulocytosis
  • vertigo
  • diarrhea
  • renal failure
  • angioedema
  • rash
  • urticaria
  • pruritus
  • increased cholesterol
  • increased triglycerides
  • deep vein thrombosis
  • thrombocytopenia
  • aplastic anemia
  • hemolytic anemia
  • bone marrow suppression
  • sensory disturbances
  • blurred vision
  • choroidal exudate
  • acute myopia
  • acute angle-closure glaucoma
  • dyspnea
  • acute respiratory distress syndrome
  • appetite loss
  • reduced appetite
  • gastrointestinal irritation
  • constipation
  • pancreatitis
  • interstitial nephritis
  • rash
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus erythematosus-like reaction
  • activation of lupus erythematosus
  • muscle cramps
  • hyperkalemia
  • hyponatremia
  • increased liver enzyme levels
  • abnormal liver function
  • hepatitis
  • orthostatic hypotension
  • necrotizing vasculitis
  • weakness
  • fever
  • anaphylactic reaction
  • jaundice
  • sleep disturbances
  • depression
  • anxiety
  • edema
  • myalgia
  • hypercalcemia
  • pain during menstruation

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Additionally, to maintain the effectiveness of the medicine, it is important to store it in a cool place, below 30 degrees Celsius.

Appearance and packaging

Appearance

Biconvex, pale pink rectangular tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.